Caricamento...
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Peripheral T-cell lymphoma (PTCL) is a set of rare and highly heterogeneous group of mature T- and NK-cell neoplasms associated with poor outcomes and lack of standard and effective therapies. The total number of newly diagnosed cases of PTCL yearly in China is estimated about 50,000. Chidamide (CS0...
Salvato in:
| Pubblicato in: | Intractable Rare Dis Res |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995415/ https://ncbi.nlm.nih.gov/pubmed/27672541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01024 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|